Eli Lilly can proceed with lawsuit against telehealth seller of weight-loss drugs
The pharma giant claimed Mochi Health's sale of altered compounded versions of popular weight-loss drugs like Zepbound and Mounjaro amounted to unfair competition, and misled consumers.
Original Source
Read the full article at Courthousenews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.